Iqvia debuts clinical data analytics intelligence platform

By The Science Advisory Board staff writers

April 28, 2021 -- Iqvia has debuted a clinical data analytics intelligence platform to accelerate vaccine development and drug discovery.

Iqvia's Connected Intelligence has the following features:

    • Connects data, analytics, and services to accelerate 350 ongoing studies to find COVID-19 treatments and vaccines
    • Deploys technologies to enroll participants in 60 ongoing trials in 40 countries
    • Accelerates drug discovery by connecting companies, researchers, and government agencies
    • Links real-world data and healthcare expertise to enable COVID-19 contact tracing and testing.
    COVID-19 computing consortium focusing on near-term COVID-19 therapies
    The COVID-19 High Performance Computing Consortium said that it has entered a new phase of operation focused on helping researchers identify potential...
    PerkinElmer launches free COVID-19 data dashboards
    PerkinElmer has launched two free, open access COVID-19 data dashboards to speed up the discovery of antivirals and vaccines for the infection.

    Copyright © 2021

CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter